Your browser doesn't support javascript.
loading
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trial.
Koc, Özgür M; de Smedt, Philippe; Kremer, Cécile; Robaeys, Geert; van Damme, Pierre; Hens, Niel; Almeida, Jorge; Falkenberg, Frank; Savelkoul, Paul; Oude Lashof, Astrid.
Afiliação
  • Koc ÖM; Department of Medical Microbiology, School of NUTRIM, Maastricht UMC+, Maastricht, The Netherlands.
  • de Smedt P; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Kremer C; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
  • Robaeys G; Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, Antwerp University, Antwerp, Belgium.
  • van Damme P; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
  • Hens N; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Almeida J; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
  • Falkenberg F; Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.
  • Savelkoul P; Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, Antwerp University, Antwerp, Belgium.
  • Oude Lashof A; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Liver Int ; 41(10): 2318-2327, 2021 10.
Article em En | MEDLINE | ID: mdl-33966331

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite B / Hepatite B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite B / Hepatite B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article